Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.75
-1.29 (-3.68%)
At close: Mar 9, 2026, 4:00 PM EDT
33.50
-0.25 (-0.74%)
After-hours: Mar 9, 2026, 6:55 PM EDT
Tyra Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 77.39 | 91.97 | 58.01 | 251.21 | 302.18 | Upgrade
|
| Short-Term Investments | 178.62 | 249.48 | 145.46 | - | - | Upgrade
|
| Cash & Short-Term Investments | 256 | 341.44 | 203.47 | 251.21 | 302.18 | Upgrade
|
| Cash Growth | -25.02% | 67.81% | -19.00% | -16.87% | 1884.90% | Upgrade
|
| Other Receivables | 1.9 | 2 | 0.7 | - | - | Upgrade
|
| Receivables | 1.9 | 2 | 0.7 | - | - | Upgrade
|
| Prepaid Expenses | 7.55 | 4.02 | 7.5 | 6.08 | 1.88 | Upgrade
|
| Total Current Assets | 265.45 | 347.46 | 211.67 | 257.29 | 304.06 | Upgrade
|
| Property, Plant & Equipment | 6.89 | 7.72 | 8.15 | 3.54 | 2.09 | Upgrade
|
| Other Long-Term Assets | 10.27 | 8.38 | 6.03 | 5.35 | 0.56 | Upgrade
|
| Total Assets | 282.61 | 363.56 | 225.86 | 266.18 | 306.7 | Upgrade
|
| Accounts Payable | 1.18 | 0.59 | 4.66 | 1.15 | 0.55 | Upgrade
|
| Accrued Expenses | 16.44 | 13.59 | 10.39 | 4.42 | 2.86 | Upgrade
|
| Current Portion of Leases | 0.47 | 0.41 | 0.28 | 0.14 | 0.2 | Upgrade
|
| Total Current Liabilities | 18.09 | 14.59 | 15.33 | 5.7 | 3.62 | Upgrade
|
| Long-Term Leases | 5.34 | 5.81 | 6.22 | 2.48 | 0.98 | Upgrade
|
| Other Long-Term Liabilities | - | 0 | 0.05 | 0.17 | 0.37 | Upgrade
|
| Total Liabilities | 23.43 | 20.41 | 21.6 | 8.35 | 4.96 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 630.04 | 593.69 | 368.71 | 353.52 | 342.1 | Upgrade
|
| Retained Earnings | -371.26 | -251.31 | -164.83 | -95.7 | -40.37 | Upgrade
|
| Comprehensive Income & Other | 0.39 | 0.77 | 0.38 | - | - | Upgrade
|
| Total Common Equity | 259.18 | 343.15 | 204.26 | 257.83 | 301.74 | Upgrade
|
| Shareholders' Equity | 259.18 | 343.15 | 204.26 | 257.83 | 301.74 | Upgrade
|
| Total Liabilities & Equity | 282.61 | 363.56 | 225.86 | 266.18 | 306.7 | Upgrade
|
| Total Debt | 5.81 | 6.22 | 6.5 | 2.62 | 1.18 | Upgrade
|
| Net Cash (Debt) | 250.19 | 335.22 | 196.97 | 248.59 | 301 | Upgrade
|
| Net Cash Growth | -25.36% | 70.19% | -20.76% | -17.41% | 1895.75% | Upgrade
|
| Net Cash Per Share | 4.20 | 5.86 | 4.61 | 5.94 | 21.84 | Upgrade
|
| Filing Date Shares Outstanding | 53.87 | 53.09 | 52.52 | 42.43 | 41.11 | Upgrade
|
| Total Common Shares Outstanding | 53.71 | 50.75 | 43.02 | 42.35 | 40.95 | Upgrade
|
| Working Capital | 247.36 | 332.87 | 196.34 | 251.59 | 300.44 | Upgrade
|
| Book Value Per Share | 4.83 | 6.76 | 4.75 | 6.09 | 7.37 | Upgrade
|
| Tangible Book Value | 259.18 | 343.15 | 204.26 | 257.83 | 301.74 | Upgrade
|
| Tangible Book Value Per Share | 4.83 | 6.76 | 4.75 | 6.09 | 7.37 | Upgrade
|
| Machinery | - | - | 2.03 | 1.38 | 1.06 | Upgrade
|
| Leasehold Improvements | - | - | 0.4 | 0.16 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.